IPSC · Century Therapeutics, Inc.
$2.07
+0.05 (+2.48%)
At close · Aug 21
Market Cap
$372.11M
Shares
181.08M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.07
Open$2.05
Day$2.02–2.09
52W close$0.47–2.94
Avg vol 30d685K
Short int29.8M · 16.5% float · 40.7d
Short vol71%
Last earningsMar 19, 2025
DataJun 2021–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+11%
above
Price vs 50-day avg
−5%
below
RSI (14)
51
neutral
MACD trend
Positive
52-week position
65%
mid-range
Momentum
relative strength
1-month return
−2%
trailing
6-month return
−8%
trailing
YTD return
+108%
this year
Relative strength
−20%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+34% holders QoQ · +35 funds added
Insider flow
Distributing
Net -$11.6K over 90 days · 100% sells
Short interest
Rising
16.47% of float · ▲ +5.1% MoM · 40.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 3-yr high, broad support
Squeeze score
68
elevated · 0–100
Fundamentals
Revenue growth
+1557%
Y/Y
EPS growth
+91%
Y/Y
Free cash flow
$-104.7M
Balance sheet
$58.1M
net cash
Quant / Vol
risk profile
Volatility
97%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
5.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+11%
Bullish
Price vs 50-day avg
−5%
Neutral
RSI (14)
51
Neutral
MACD trend
Positive
Bullish
52-week position
65%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $2 › 200d $2 — 50d above 200d
Institutional flow
Accumulating
+34% holders QoQ · +35 funds added
Insider flow
Distributing
Net -$11.6K over 90 days · 100% sells
Short interest
Rising
16.47% of float · ▲ +5.1% MoM · 40.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
99 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $0
Now $2 · 65%
Range high $3
vs 200-day avg +11%
vs 50-day avg -5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IPSC
this stock
Century Therapeutics, Inc.
|
$372.11M | +108.0% | +1556.8% | — | 16.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +20.9% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.56B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$58.31B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IPSC | +7.8% | -1.9% | -8.4% | +2.5% | +108.0% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +9.2% | -5.5% | -20.0% | 0.0% | +95.8% |
Key facts
CIK
1850119
CUSIP
15673T100
13F (30d)
96 filings
95 filers
Visit website
Investor relations